Regulus Therapeutics Inc Earnings

The next earnings date for Regulus Therapeutics Inc is August 12, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Regulus Therapeutics Inc Earnings

Report DateEstimated Earnings Per Share
08/12/2025$-0.22

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Regulus Therapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/07/2025After Market$-0.1543.40%
03/19/2025Before Market$-0.2010.11%
11/07/2024After Market$-0.21-23.53%
08/08/2024After Market$-0.17-13.33%
05/09/2024After Market$-0.29-31.82%
03/21/2024After Market$-0.40-2.56%
11/09/2023After Market$-0.400.00%
08/08/2023After Market$-0.379.76%
05/11/2023After Market$-0.424.55%
03/23/2023After Market$-0.4021.57%
11/10/2022After Market$-0.50-2.04%
08/11/2022After Market$-0.50-4.17%
05/12/2022After Market$-0.505.66%
03/10/2022After Market$-0.70-4.48%
11/10/2021After Market$-1-29.87%
08/10/2021After Market$-0.800.00%
05/13/2021After Market$-0.8011.11%
03/09/2021After Market$-0.3078.57%
11/05/2020After Market$-0.4080.77%
08/13/2020After Market$-2.30-114.95%
05/14/2020After Market$-2.50-108.33%
03/12/2020After Market$-2.304.17%
11/12/2019After Market$-2.600.76%
08/08/2019After Market$-344.75%
05/09/2019After Market$-3.1073.04%
03/18/2019Before Market$-9.80-6.75%
11/08/2018After Market$-11.805.75%
08/09/2018After Market$-15.6016.13%
05/10/2018After Market$-18-1.35%
03/07/2018After Market$-16.8011.72%
11/07/2017After Market$-21.60-11.34%
08/01/2017After Market$-49.20-23.71%
05/04/2017After Market$-45.60-10.14%
03/02/2017After Market$-45.60-3.90%
11/01/2016After Market$-44.407.04%
08/02/2016After Market$-48-5.61%
05/02/2016After Market$-48-21.83%
02/22/2016After Market$-16.8043.62%
11/05/2015After Market$-3032.43%
08/04/2015After Market$-49.20-43.86%
05/07/2015After Market$-34.80-13.28%
02/18/2015After Market$-56.40-121.18%
11/05/2014After Market$-27.601.71%
08/06/2014---$-34.80-53.98%
05/08/2014---$-36-108.33%
02/27/2014---$-13.2012.70%
11/13/2013---$-666.22%
08/13/2013---$-24-42.86%
05/14/2013---$-24-81.82%
02/20/2013---$-26.40-205.56%
11/19/2012---$-1.2094.00%

More About Regulus Therapeutics Inc

Website
https://www.regulusrx.com
Country
USA
Full Time Employees
34

Regulus Therapeutics Inc. engages in the development of drugs designed to inhibit dysregulated microRNA targets for the benefit of patients with genetically based orphan diseases. The company develops farabursen, an anti-miR oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease. It is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was formerly known as Regulus Therapeutics LLC and changed its name to Regulus Therapeutics Inc. in January 2009. The company was incorporated in 2007 and is based in San Diego, California. As of June 25, 2025, Regulus Therapeutics Inc. operates as a subsidiary of Novartis AG.

“Regulus Therapeutics Inc Earnings” Can Refer to the Regulus Therapeutics Inc Earnings Date

Some people say “Regulus Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Regulus Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Regulus Therapeutics Inc Stock on the Earnings Date

If you own Regulus Therapeutics Inc stock (RGLS) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Regulus Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Regulus Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Regulus Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Regulus Therapeutics Inc earnings or anything else related to the stock market.